AI assistant
KALA BIO, Inc. — Director's Dealing 2024
Jun 13, 2024
35091_dirs_2024-06-12_4e64a31c-b049-4288-b7b9-869df6493670.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: KALA BIO, Inc. (KALA)
CIK: 0001479419
Period of Report: 2024-06-11
Reporting Person: Myers C. Daniel (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-11 | Common Stock | A | 1400 | — | Acquired | 7924 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-11 | Stock Option (right to buy) | $6.18 | A | 3150 | Acquired | 2034-06-10 | Common Stock (3150) | Direct |
Footnotes
F1: Grant of restricted stock units ("RSUs") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 100% of the shares underlying the grant on the earlier of (i) June 11, 2025 or (ii) the date of the first annual meeting following June 11, 2024.
F2: Includes 6,603 unvested RSUs.
F3: This option was granted on June 11, 2024 and vests as to 100% of the shares underlying the grant on the earlier of (i) June 11, 2025 or (ii) the date of the first annual meeting following June 11, 2024.